Compare Definium Therapeutics Inc. Common Shares (DFTX) vs iShares Core High Dividend ETF (HDV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs iShares Core High Dividend ETF — how do they compare? Definium Therapeutics Inc. Common Shares trades at $36.8 (market cap $4.59B), while iShares Core High Dividend ETF trades at $28.69 (market cap $14.68B). The key difference: iShares Core High Dividend ETF is far larger — about 3.2× Definium Therapeutics Inc. Common Shares's market cap, and iShares Core High Dividend ETF is trading nearer its 52-week high, Definium Therapeutics Inc. Common Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and iShares Core High Dividend ETF for 117 Days on average.
| DFTX | HDV | |
|---|---|---|
Market Cap | $4.59B | $14.68B |
Volume | 2,103,937 | 2,925,562 |
Sector | Health | — |
52-Week High | $48.45 | $29.93 |
52-Week Low | $10.68 | $23.64 |
Typical Hold Time | 0 Days | 117 Days |
Enterprise Value | $3.55B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
HDV (iShares Core High Dividend ETF) trades at $28.72, up 1.56% today with a bullish technical signal supported by moving averages. The ETF recently underwent a significant sector rebalancing, reducing healthcare exposure while increasing energy, staples, and utilities, resulting in heightened concentration risk with nearly 62% allocation to three sectors. Recent dividend payments of $0.06-$0.10 per share demonstrate consistent income generation despite the 3% yield not fully compensating for reduced diversification.
The outlook remains cautiously optimistic given the ETF's strong 2026 performance against the S&P 500, though investors face concentration risks from the recent sector shift. Key opportunities include the fund's competitive 0.08% expense ratio and dividend focus during market rotation, while risks center on sector concentration and whether the current yield adequately compensates for reduced diversification in the portfolio construction.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About iShares Core High Dividend ETF
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index is comprised of qualified income paying securities that are screened for superior company quality and financial health as determined by Morningstar, Inc.'s proprietary index methodology. The fund is non-diversified.
Read more on HDV →
